Centre Hospitalier Universitaire de Bordeaux - Hôpital Haut Lévêque

Pessac 33604

0 studies enrolling now · 1 studies all time

What they study most

Relapsed or Refractory Multiple Myeloma

Studies at this site

• Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet — Completed